News archive

3D model provides better understanding of metastatic cancer

FRIDAY 14 JULY 2006

A new imaging method has given scientists a 3-D view of how cancer cells spread around the body, a process known as metastasis.

The discovery significantly improves our understanding of the process.

Many researchers around the world are trying to develop new drugs to block cancer spread, and developing accurate ways to test their effectiveness is key.

Previous attempts to test the effectiveness of new anti-metastatic drugs used two-dimensional systems and only measured cancer cells? ability to move along a flat 2-D surface.

The finding that cancer cells react differently in a 3D system explains why previous tests had failed to properly predict how the drugs would work in living systems.

Cells in fact move very differently in 3-D, said researcher and assistant professor Muhammad Zaman.

"Two-dimensional assays [experiments] ignore the obstacles that cells face in their natural contexts," he said.

"In 3-D, cells move through a thick jungle of fibres that hinder forward progress."

The imaging technology required remains too complex and intensive for regular use however, with almost a year's work required to gather the data for the study.

The research was conducted by the Massachusetts Institute of Technology and published in the Proceedings of the National Academy of Sciences.



Find out more about how cancers spread

News provided by Adfero in collaboration with Cancer Research UK. Please note that all copy is © Adfero Ltd and does not reflect the views or opinions of Cancer Research UK unless explicitly stated.


* Number of Britons diagnosed with alcohol-related cancers exceeds Wimbledon's Centre Court
* Benefits of international tobacco smuggling protocol would outweigh costs
* Women and GPs lack awareness of ovarian cancer symptoms
* One in 25 deaths attributable to alcohol
* Patients with suspected cancer to see specialist within two weeks
* Animal fats linked to pancreatic cancer
* Promising experimental drug targets cancer 'Achilles heel'
* Cervical cancer screening age to stay at 25
* NICE approves lenalidomide for multiple myeloma patients who have received previous treatments
* Scientists identify inhibitor of tumour spread
A - Z index A - Z index
Contact us Contact us
Donate now Donate now
Glossary Glossary
Print this page Print this page
AddThis Feed Button

 
 
About this site   Accessibility   Donate now   Privacy   Site Map   Terms & Conditions   Top of page

Cancer Research UK is a registered charity No. 1089464.
Registered as a company limited by guarantee in England & Wales No. 4325234.
Registered address 61 Lincoln's Inn Fields, London, WC2A 3PX.